Coronavirus disease-19: The multi-level, multi-faceted vasculopathy
- 15 February 2021
- journal article
- review article
- Published by Elsevier BV in Atherosclerosis
- Vol. 322, 39-50
- https://doi.org/10.1016/j.atherosclerosis.2021.02.009
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal TractsPLOS ONE, 2012
- Structure and Composition of Pulmonary Arteries, Capillaries, and VeinsComprehensive Physiology, 2012
- Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus InfectionCell, 2011
- Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cellsProceedings of the National Academy of Sciences of the United States of America, 2010
- SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARSEuropean Journal of Clinical Investigation, 2009
- Platelets, Petechiae, and Preservation of the Vascular WallThe New England Journal of Medicine, 2008
- Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2PLOS ONE, 2007
- Angiotensin-(1-7) Through Receptor Mas Mediates Endothelial Nitric Oxide Synthase Activation via Akt-Dependent PathwaysHypertension, 2007
- Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to PathogenesisJournal of Virology, 2005
- Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex.The Journal of Experimental Medicine, 1979